3billion

We’re proud to share that 3billion has achieved the ISO/IEC 27001:2022 certification – an internationally recognized standard for Information Security Management Systems (ISMS). This accomplishment reaffirms our unwavering commitment to protecting sensitive patient genetic data and upholding the highest standards in information security throughout our genetic testing processes and software solutions. https://lnkd.in/gASSQabg #InformationSecurity #GeneticTesting #3billion

This study, led by Dr. Hong, analyzed genetic variants in Korean patients with suspected hypertrophic cardiomyopathy (HCM) using a next-generation sequencing (NGS) panel and the 3billion's EXOME (https://lnkd.in/gAbEztAx). Of the 492 patients tested, 43.5% were found to have disease-causing variants. The majority (90.9%) were diagnosed with HCM linked to sarcomere gene variants, while 5.5% were diagnosed with Fabry disease. Notably, patients with positive sarcomere gene variants had significantly worse outcomes. In addition, the prevalence of Fabry disease in this study (5.5%) was higher than previously reported rates of 0.5–2%, likely due to the focused screening of high-risk patients at specialized HCM and Fabry clinics. Genetic testing for patients with suspected HCM provides a definitive molecular diagnosis, allows for the prediction of clinical outcomes, and opens the door to appropriate treatments. #fabrydisease #HCMP #3billion #enzymereplacementherapy

A recent survey of 32 eligible CLIA-certified, CAP-accredited clinical genetic laboratories in the U.S. revealed some key insights into reanalysis practices for exome and genome sequencing (https://lnkd.in/gSXz_YFk). ✅ More than 90% of these labs provide reanalysis, with 96% offering exome and 92% offering genome reanalysis. However, the majority of reanalyses are conducted only upon a doctor’s request. Only one lab reanalyzes results automatically, and two labs have a hybrid approach—reanalyzing both automatically and upon request. ✅ Regarding the cost of reanalysis, 50% of labs offer the first reanalysis for free, while 28% charge for every reanalysis, and 17% always offer it for free.  ✅ The cost ranges from $250 to $1,000, with prices never going below $250.  ✅ Notably, the frequency of reanalysis requests remains low; more than half of the labs receive requests for reanalysis in less than 11% of their cases. ✅ Accessing information about reanalysis seems challenging: 66% of labs provide details on their websites, 38% mention it during the ordering process, 38% inform customers at the billing stage, and only 13% explain the process during the initial ordering. I believe that 3billion approach to reanalysis stands out. Reanalysis is well-communicated during the ordering process, and the fact that we automatically conduct reanalyses on a daily offers a significant advantage. This proactive approach has the potential to maximize the utility of reanalysis for our customers, ensuring they receive the most up-to-date and accurate information possible. #3billion #reanalysis #exome #genome #raredisease

🧬3billion October Newsletter is Here! This edition brings exciting updates, including welcoming visitors from UDNI, advancements in Whole Exome Sequencing (WES), and a deep dive into a Neurofibromatosis Type 1 (NF1) case. We're sharing valuable insights to help you stay ahead in the field of genetics. Curious to learn more? 👉Read Now #RareDisease #GeneticTesting #NF1 #WES #rarediseasediagnosis #ResearchAdvancements #3billion

3billion attended the Inaugural Malaysian Conference on Paediatrics & Child Health in Sibu, Malaysia, from October 4-6, 2024. Our Chief Medical Officer, Dr. GoHun Seo attended the conference with Jane Han and Minjin Park. It was a valuable opportunity to engage with pediatricians from across Malaysia. We are pleased to share that Dr. Gohun Seo and Dr. Ngu Lock-Hock from Hospital Kuala Lumpur delivered an impactful presentation on advancing genetic diagnostics for pediatric patients with rare diseases. We trust that this session provided meaningful insights for all attendees. Thank you to all the attendees, speakers, and organizers for making this event a success. We look forward to continuing our collaboration with the medical community to make a difference in pediatric care. Special thanks to Dr. Teck-Hock Toh, the chair of the organization for inviting us to this amazing event and showing us around Sibu. We enjoyed our trip to Lau King Howe Hospital Memorial Museum and Agape Centre after the conference. Your work in the medical community is truly inspiring. Once again thank you for having us in this beautiful city. To our great supporter, Dr. Ngu Lock-Hock from Hospital Kuala Lumpur, thank you for presenting with 3billion. Your work will guide other professionals in the industry toward more efficient diagnostic pathways. Also nice to catch up with Erin Koek from BioMarin finally in Sibu!  #Pediatrics #Genetic #Diagnostics #3billion #Healthcare #WES #WGS #RareDisease

🇨🇱 3billion Team in Chile! This week, our team had an incredible opportunity to visit Chile and engage with leading healthcare professionals. We had insightful conversations about how 3billion is transforming the clinical genetic testing experience for patients and medical practitioners alike. Our goal is to solve their problems, by ensuring they get faster, more accurate, and accessible genetic testing. Together, we’re paving the way for better patient outcomes in rare disease diagnostics across the globe. #ClinicalGenetics #HealthcareInnovation #ChileVisit #RareDiseases #Genomics #3billion

3billion is looking forward to this important session at #CNGH2024, #AMGH 2024 in November. We’re excited to hear from Dr. Seung Woo Ryu as he shares his insights on the challenges and opportunities in genetic counseling across diverse cultural contexts. Thank you to everyone joining us, and we anticipate an engaging and meaningful discussion ahead! --- 3billion espera con entusiasmo esta importante sesión en #CNGH2024, #AMGH2024 en noviembre. Estamos emocionados de escuchar al Dr. Seung Woo Ryu mientras comparte sus ideas sobre los retos y oportunidades del asesoramiento genético en diversos contextos culturales. Gracias a todos los que nos acompañarán, ¡y anticipamos una discusión comprometida y significativa! #AMGH2024 #GeneticCounseling #Genomics #Healthcare #3billion

🧬 Join our first-ever webinar for medical professionals in Central Asia! 🧬 "Genetic Testing: When, How, and What to Do with the Results?" This is our inaugural webinar tailored specifically for geneticists, pediatricians, and neurologists in Central Asia. Topics include: - The importance of Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) - How to choose the right test and interpret the results - Practical steps to improve patient outcomes with advanced genetic testing Speaker: Dr. Rauan Kaiyrzhanov, MD, PhD Neurologist & Neurogeneticist South Kazakhstan Medical Academy 📅 Date: 30th September 🕒 Time: 4 PM 🔗 Webinar Link: https://lnkd.in/gCsTUDXa Don’t miss out on this exclusive event! Feel free to share it with your colleagues. *The webinar will be held in Russian and English. #GeneticTesting #CentralAsia #WES #WGS #raredisease #3billion #Neurology #Pediatrics

We’re delighted to host Dr. Vasilica Plaiasu, Dr. Elena Neagu, and Dr. Irina Apostol from Romania at our Korea office!  Good luck to our partners for their presentation at UDNI 2024. #UDNI2024 #RareDiseases #3billion

Today, we had the privilege of hosting Dr. Shahida Moosa, who has been a valued collaborator since 2021. We hope you have a great time visiting Korea, Prof. Shahida Moosa. Through collaborations like this, we aim to improve access to genetic diagnoses and precision medicine globally.  #RareDiseases #GlobalCollaboration #3billionCollaborations